These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 26442661
1. Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent. Frau L, Costa G, Porceddu PF, Khairnar A, Castelli MP, Ennas MG, Madeddu C, Wardas J, Morelli M. J Neurochem; 2016 Jan; 136(1):148-62. PubMed ID: 26442661 [Abstract] [Full Text] [Related]
2. MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice. Costa G, Frau L, Wardas J, Pinna A, Plumitallo A, Morelli M. Mov Disord; 2013 Dec; 28(14):1957-65. PubMed ID: 24108425 [Abstract] [Full Text] [Related]
4. Repeated Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Elevates the Levels of Neuronal Nitric Oxide Synthase in the Nigrostriatal System: Possible Relevance to Neurotoxicity. Costa G, Morelli M, Simola N. Neurotox Res; 2018 Nov; 34(4):763-768. PubMed ID: 29629511 [Abstract] [Full Text] [Related]
5. In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice. Costa G, Spulber S, Paci E, Casu MA, Ceccatelli S, Simola N, Morelli M. Neurotoxicology; 2021 Mar; 83():1-13. PubMed ID: 33338551 [Abstract] [Full Text] [Related]
6. Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain. Frau L, Simola N, Porceddu PF, Morelli M. Neurotoxicology; 2016 Sep; 56():127-138. PubMed ID: 27451954 [Abstract] [Full Text] [Related]
7. Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age. Costa G, Porceddu PF, Serra M, Casu MA, Schiano V, Napolitano F, Pinna A, Usiello A, Morelli M. Int J Mol Sci; 2019 Mar 28; 20(7):. PubMed ID: 30925704 [Abstract] [Full Text] [Related]
8. Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence. Cadoni C, Pisanu A, Simola N, Frau L, Porceddu PF, Corongiu S, Dessì C, Sil A, Plumitallo A, Wardas J, Di Chiara G. Neuropharmacology; 2017 Sep 01; 123():385-394. PubMed ID: 28603026 [Abstract] [Full Text] [Related]
9. Caffeine enhances astroglia and microglia reactivity induced by 3,4-methylenedioxymethamphetamine ('ecstasy') in mouse brain. Khairnar A, Plumitallo A, Frau L, Schintu N, Morelli M. Neurotox Res; 2010 May 01; 17(4):435-9. PubMed ID: 19882200 [Abstract] [Full Text] [Related]
10. Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice. Granado N, O'Shea E, Bove J, Vila M, Colado MI, Moratalla R. J Neurochem; 2008 Nov 01; 107(4):1102-12. PubMed ID: 18823368 [Abstract] [Full Text] [Related]
11. Rhes Counteracts Dopamine Neuron Degeneration and Neuroinflammation Depending on Gender and Age. Costa G, Pinna A, Porceddu PF, Casu MA, Di Maio A, Napolitano F, Usiello A, Morelli M. Front Aging Neurosci; 2018 Nov 01; 10():163. PubMed ID: 29904346 [Abstract] [Full Text] [Related]
13. Role of neuronal nitric oxide synthase in slowly progressive dopaminergic neurodegeneration in the Zitter rat. Ehara A, Nakadate K, Sugimoto H, Yoshimoto K, Ueda S. Nitric Oxide; 2018 Aug 01; 78():41-50. PubMed ID: 29792933 [Abstract] [Full Text] [Related]
14. Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease. Frau L, Borsini F, Wardas J, Khairnar AS, Schintu N, Morelli M. Synapse; 2011 Mar 01; 65(3):181-8. PubMed ID: 20665698 [Abstract] [Full Text] [Related]
15. Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility. Frau L, Simola N, Plumitallo A, Morelli M. J Neurochem; 2013 Jan 01; 124(1):69-78. PubMed ID: 23083295 [Abstract] [Full Text] [Related]
16. Adolescent exposure to MDMA induces dopaminergic toxicity in substantia nigra and potentiates the amyloid plaque deposition in the striatum of APPswe/PS1dE9 mice. Abad S, Ramon C, Pubill D, Camarasa J, Camins A, Escubedo E. Biochim Biophys Acta; 2016 Sep 01; 1862(9):1815-26. PubMed ID: 27344237 [Abstract] [Full Text] [Related]
17. Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage. Costa G, Morelli M, Simola N. Neurotox Res; 2017 Nov 01; 32(4):563-574. PubMed ID: 28597409 [Abstract] [Full Text] [Related]
18. Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson's disease. Schintu N, Frau L, Ibba M, Garau A, Carboni E, Carta AR. Neurotox Res; 2009 Aug 01; 16(2):127-39. PubMed ID: 19526289 [Abstract] [Full Text] [Related]
19. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain. Colado MI, Camarero J, Mechan AO, Sanchez V, Esteban B, Elliott JM, Green AR. Br J Pharmacol; 2001 Dec 01; 134(8):1711-23. PubMed ID: 11739248 [Abstract] [Full Text] [Related]
20. Switching the microglial harmful phenotype promotes lifelong restoration of subtantia nigra dopaminergic neurons from inflammatory neurodegeneration in aged mice. L'episcopo F, Tirolo C, Testa N, Caniglia S, Morale MC, Impagnatiello F, Marchetti B. Rejuvenation Res; 2011 Aug 01; 14(4):411-24. PubMed ID: 21793734 [Abstract] [Full Text] [Related] Page: [Next] [New Search]